Professor Sandi Deans is the Genomic Scientific and Laboratory Deputy Director in the Genomics Unit, NHS England and NHS Improvement embedding the National Genomic Medicine Service for rare disease and cancer including whole genome sequencing within the NHS. The mainstreaming of cancer genomics is being achieved through new pathways, availability of large gene panel testing and integration into existing clinical teams.
Sandi holds a chair as Professor of Clinical Genomics at the University of Edinburgh. She also is a Consultant Clinical Scientist and the Director of Genomics Quality Assessment part of the UK National External Quality Assessment Service (UK NEQAS). The EQA Scheme delivers assessment of molecular genetics, molecular pathology and cytogenomic testing, newborn screening, prenatal diagnosis, preimplantation genetic diagnosis and variant interpretation.
During 2020-21, Sandi was Head of Laboratory Validation and Quality Assurance for SARS-CoV-2 testing for mass testing in NHS Test and Trace.